Cargando…
Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway
BACKGROUND: Epithelial to Mesenchymal Transition (EMT) induced by Transforming Growth Factor-β (TGF-β) is an important cellular event in organogenesis, cancer, and organ fibrosis. The process to reverse EMT is not well established. Our purpose is to define signaling pathways and transcription factor...
Autores principales: | Das, Shreyas, Becker, Bryan N, Hoffmann, F Michael, Mertz, Janet E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806300/ https://www.ncbi.nlm.nih.gov/pubmed/20025777 http://dx.doi.org/10.1186/1471-2121-10-94 |
Ejemplares similares
-
Reversal of transforming growth factor-β induced epithelial-to-mesenchymal transition and the ZEB proteins
por: Das, Shreyasi, et al.
Publicado: (2012) -
Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1
por: Carriere, Patrick P., et al.
Publicado: (2015) -
FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition
por: Dong, Tianxiu, et al.
Publicado: (2016) -
Human Schlafen 5 regulates reversible epithelial and mesenchymal transitions in breast cancer by suppression of ZEB1 transcription
por: Wan, Guoqing, et al.
Publicado: (2020) -
p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
por: Kim, Taewan, et al.
Publicado: (2011)